In the US, Erythrocin Lactobionate (erythromycin systemic) is a member of the drug class macrolides and is used to treat Bacterial Endocarditis Prevention, Bowel Preparation, Bronchitis, Bullous Pemphigoid, Campylobacter Gastroenteritis, Chancroid, Chlamydia Infection, Dental Abscess, Legionella Pneumonia, Lyme Disease, Lymphogranuloma Venereum, Mycoplasma Pneumonia, Nongonococcal Urethritis, Otitis Media, Pemphigoid, Pharyngitis, Pneumonia, Rheumatic Fever Prophylaxis, Skin Infection, Strep Throat, Syphilis - Early and Upper Respiratory Tract Infection.
US matches:
- Erythrocin Lactobionate
Ingredient matches for Erythrocin Lactobionate
Erythromycin
Erythromycin lactobionate (a derivative of Erythromycin) is reported as an ingredient of Erythrocin Lactobionate in the following countries:
- Austria
- Israel
- Singapore
- United States
International Drug Name Search
No comments:
Post a Comment